Invesaro

Stocks Comparison

Amgen vs Qiagen: revenue, profit, margins and growth compared

Amgen brought in $36.8B of revenue in fiscal 2025, Qiagen $2.1B in fiscal 2025. Revenue changed by +10.0% at Amgen and +5.7% at Qiagen on the year before, so Amgen grew faster. Amgen kept 21.0% of its revenue as net profit, Qiagen 20.3%. Free cash flow was $8.1B at Amgen and $453.3M at Qiagen.

Side by side, latest fiscal year

AMGNQGEN
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$36.8B$2.1B
Revenue growth+10.0%+5.7%
Net income$7.7B$424.9M
Net margin21.0%20.3%
Free cash flow$8.1B$453.3M
Free cash flow margin22.0%21.7%
Earnings per share (diluted)$14.23$1.94
Cash$9.1B$839M
Debt$54.6B$1.7B
Price to earnings29.1n/a
Market value$224.2B$9.1B
Dividend yield2.33%n/a
Rank by revenue in sector#20 of 523 · Health care#107 of 523 · Health care

Over the years

Revenue
AMGN FY2018: $23.7BAMGN FY2019: $23.4BAMGN FY2020: $25.4BAMGN FY2021: $26BAMGN FY2022: $26.3BAMGN FY2023: $28.2BAMGN FY2024: $33.4BAMGN FY2025: $36.8BQGEN FY2018: $1.5BQGEN FY2019: $1.5BQGEN FY2020: $1.9BQGEN FY2021: $2.3BQGEN FY2022: $2.1BQGEN FY2023: $2BQGEN FY2024: $2BQGEN FY2025: $2.1BFY18FY19FY20FY21FY22FY23FY24FY25
AMGN $36.8BQGEN $2.1B
Net income
AMGN FY2018: $8.4BAMGN FY2019: $7.8BAMGN FY2020: $7.3BAMGN FY2021: $5.9BAMGN FY2022: $6.6BAMGN FY2023: $6.7BAMGN FY2024: $4.1BAMGN FY2025: $7.7BQGEN FY2018: $190.4MQGEN FY2019: -$41.5MQGEN FY2020: $359.2MQGEN FY2021: $512.6MQGEN FY2022: $423.2MQGEN FY2023: $341.3MQGEN FY2024: $83.6MQGEN FY2025: $424.9MFY18FY19FY20FY21FY22FY23FY24FY25
AMGN $7.7BQGEN $424.9M
Net margin
AMGN FY2018: 35.3%AMGN FY2019: 33.6%AMGN FY2020: 28.6%AMGN FY2021: 22.7%AMGN FY2022: 24.9%AMGN FY2023: 23.8%AMGN FY2024: 12.2%AMGN FY2025: 21.0%QGEN FY2018: 12.7%QGEN FY2019: -2.7%QGEN FY2020: 19.2%QGEN FY2021: 22.8%QGEN FY2022: 19.8%QGEN FY2023: 17.4%QGEN FY2024: 4.2%QGEN FY2025: 20.3%FY18FY19FY20FY21FY22FY23FY24FY25
AMGN 21.0%QGEN 20.3%
Revenue growth
AMGN FY2019: -1.6%AMGN FY2020: +8.8%AMGN FY2021: +2.2%AMGN FY2022: +1.3%AMGN FY2023: +7.1%AMGN FY2024: +18.6%AMGN FY2025: +10.0%QGEN FY2019: +1.6%QGEN FY2020: +22.5%QGEN FY2021: +20.4%QGEN FY2022: -4.9%QGEN FY2023: -8.2%QGEN FY2024: +0.7%QGEN FY2025: +5.7%FY19FY20FY21FY22FY23FY24FY25
AMGN +10.0%QGEN +5.7%
Free cash flow
AMGN FY2018: $10.6BAMGN FY2019: $8.5BAMGN FY2020: $9.9BAMGN FY2021: $8.4BAMGN FY2022: $8.8BAMGN FY2023: $7.4BAMGN FY2024: $10.4BAMGN FY2025: $8.1BQGEN FY2018: $249.7MQGEN FY2019: $212.9MQGEN FY2020: $325MQGEN FY2021: $449.1MQGEN FY2022: $586MQGEN FY2023: $309.7MQGEN FY2024: $506.4MQGEN FY2025: $453.3MFY18FY19FY20FY21FY22FY23FY24FY25
AMGN $8.1BQGEN $453.3M

Fiscal years as each company reports them; the two may end in different months.

Questions about Amgen and Qiagen

Which is bigger by revenue, Amgen or Qiagen?

Amgen is bigger by revenue: $36.8B in fiscal 2025, against $2.1B for Qiagen in fiscal 2025.

Which keeps more of its revenue as profit, Amgen or Qiagen?

Amgen had a net margin of 21.0% in fiscal 2025; Qiagen had 20.3% in fiscal 2025.

Which grew revenue faster, Amgen or Qiagen?

In their latest fiscal years revenue changed by +10.0% at Amgen and +5.7% at Qiagen.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies